Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1375 of 2228 entries
View as:

Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02254096 Org: User:
Start: 05/31/02 End: - Due: -

Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02230995 Org: User:
Start: 09/30/14 End: 10/31/14 Due: 10/31/15

BI 10773 Administered as Oral Solution to Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02172274 Org: User:
Start: 06/30/08 End: - Due: -

Headache Study to Compare Aggrenox Full Dose and Reduced Dose

Phase: N/A Priority: Normal
NCT ID: NCT00274586 Org: User:
Start: 09/30/02 End: 04/30/03 Due: 04/30/04

A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities

Phase: N/A Priority: Normal
NCT ID: NCT06107036 Org: User:
Start: 03/06/24 End: 07/25/24 Due: 07/25/25

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02273505 Org: User:
Start: 04/30/00 End: - Due: -

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Phase: N/A Priority: Normal
NCT ID: NCT05068102 Org: User:
Start: 03/03/22 End: 12/15/25 Due: 12/15/26

Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00847301 Org: User:
Start: 04/30/09 End: 07/31/14 Due: 07/31/15

Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use

Phase: N/A Priority: Normal
NCT ID: NCT02121535 Org: User:
Start: 04/30/14 End: 08/31/14 Due: 08/31/15

Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BEA 2180 BR in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02254135 Org: User:
Start: 12/31/06 End: - Due: -

Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02170623 Org: User:
Start: 02/28/02 End: - Due: -

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02170571 Org: User:
Start: 07/31/05 End: - Due: -

Long-term Observation PMS for Afatinib

Phase: N/A Priority: Normal
NCT ID: NCT02131259 Org: User:
Start: 05/07/14 End: 12/28/16 Due: 12/28/17

To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

Phase: N/A Priority: Normal
NCT ID: NCT02085161 Org: User:
Start: 03/31/14 End: 10/31/15 Due: 10/31/16

VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

Phase: N/A Priority: Normal
NCT ID: NCT00561925 Org: User:
Start: 11/30/07 End: - Due: -

Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02254070 Org: User:
Start: 06/30/03 End: - Due: -

Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT05465317 Org: User:
Start: 08/08/22 End: 05/02/23 Due: 05/02/24

Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06886009 Org: User:
Start: 06/27/25 End: 06/08/29 Due: 06/08/30

Influence of a Standardised High Fat Breakfast on the Bioavailability of BI 14332 CL in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02212938 Org: User:
Start: 09/30/06 End: - Due: -

Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01383356 Org: User:
Start: 06/30/11 End: 12/31/11 Due: 12/31/12

Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00716417 Org: User:
Start: 07/31/08 End: - Due: -

A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT05183360 Org: User:
Start: 02/03/22 End: 08/08/24 Due: 08/08/25

A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479

Phase: N/A Priority: Normal
NCT ID: NCT05440799 Org: User:
Start: 07/20/22 End: 08/02/23 Due: 08/02/24

Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin

Phase: N/A Priority: Normal
NCT ID: NCT04147260 Org: User:
Start: 11/06/19 End: 09/09/20 Due: 09/09/21

Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults

Phase: N/A Priority: Normal
NCT ID: NCT02181972 Org: User:
Start: 05/31/02 End: - Due: -